hypoxanthine has been researched along with Multiple Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalnovicová, T; Kuracka, L; Líska, B; Turcáni, P | 1 |
| Kempski, OS; Lowitzsch, K; Stover, JF | 1 |
2 other study(ies) available for hypoxanthine and Multiple Sclerosis
| Article | Year |
|---|---|
HPLC method for measurement of purine nucleotide degradation products in cerebrospinal fluid.
Topics: Adult; Brain Ischemia; Chromatography, High Pressure Liquid; Humans; Hydrogen-Ion Concentration; Hypoxanthine; Hypoxanthines; Intervertebral Disc Displacement; Middle Aged; Multiple Sclerosis; Nervous System Diseases; Purine Nucleotides; Reference Values; Subarachnoid Hemorrhage; Uric Acid; Xanthine; Xanthines | 1996 |
Cerebrospinal fluid hypoxanthine, xanthine and uric acid levels may reflect glutamate-mediated excitotoxicity in different neurological diseases.
Topics: Adult; Albumins; Central Nervous System Diseases; Cerebrovascular Disorders; Chromatography, High Pressure Liquid; Epilepsy; Female; Glutamic Acid; Humans; Hypoxanthine; L-Lactate Dehydrogenase; Lactic Acid; Male; Meningitis, Viral; Middle Aged; Multiple Sclerosis; Serum Albumin; Spinal Cord Diseases; Uric Acid; Xanthine | 1997 |